Phenotypic, functional, and single-cell transcriptomic analysis of intratumoral CD8+ T cells from both immunotherapy-resistant pre-clinical models and metastatic melanoma patients identifies that CD38-expressing CD8+ T cells are associated with anti-PD1 resistance. This evidence concerns the gene CD38 and metastatic melanoma.